Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects.
9
mentions
- X 8
- YouTube 1
PubHawk tracks social media discussions for 1 article by authors named Angelica Sette.
Mentions
Extended reach
Total likes
Video views
Tracked by PubHawk
From PubMed
Searching PubMed…